Outcomes among 3.5 million newly diagnosed hypertensive Canadians

Canadian Journal of Cardiology

Volumn 29, Issue 5, 2013, Pages 592-597

  Quan, Hude ^a   Chen, Guanmin ^a   Tu, Karen ^b,c   Bartlett, Gillian ^d   Butt, Debra A ^b,c   Campbell, Norm R C ^a,e   Hemmelgarn, Brenda R ^a,e   Hill, Michael D ^a,e,f   Johansen, Helen ^g   Khan, Nadia ^h   Lix, Lisa M ⁱ   Smith, Mark ^j   Svenson, Larry ^a,k,l   Walker, Robin L ^a   Wielgosz, Andy ^g   McAlister, Finlay A ^l  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

^f UNIVERSITY OF CALGARY   (Canada)

^g UNIVERSITY OF OTTAWA   (Canada)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

ⁱ UNIVERSITY OF SASKATCHEWAN   (Canada)

^j UNIVERSITY OF MANITOBA   (Canada)

^k Surveillance and Assessment   (Canada)

^l UNIVERSITY OF ALBERTA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ALL CAUSE MORTALITY; ARTICLE; CANADA; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; DATA BASE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY; OUTPATIENT; PATIENT CARE; POPULATION RESEARCH; RURAL AREA; SEX DIFFERENCE; TREATMENT OUTCOME; VALIDATION PROCESS;

ADULT; AGED; CANADA; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALIZATION; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK FACTORS; STROKE; YOUNG ADULT;

EID: 84876805393     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.12.016     Document Type: Article

References (33)

1. Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P.K., He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005, 365:217-223.
2. Gaziano T.A., Bitton A., Anand S., Weinstein M.C. The global cost of nonoptimal blood pressure. J Hypertens 2009, 27:1472-1477.
3. Ezzati M., Lopez A.D., Rodgers A., Vander Hoorn S., Murray C.J. Selected major risk factors and global and regional burden of disease. Lancet 2002, 360:1347-1360.
4. Kannel W.B. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996, 275:1571-1576.
5. Levy D., Larson M.G., Vasan R.S., Kannel W.B., Ho K.K. The progression from hypertension to congestive heart failure. JAMA 1996, 275:1557-1562.
6. Kannel W.B., Wolf P.A., Verter J., McNamara P.M. Epidemiologic assessment of the role of blood pressure in stroke. The Framingham Study. JAMA 1970, 214:301-310.
7. Kannel W.B., Wolf P.A. Framingham Study insights on the hazards of elevated blood pressure. JAMA 2008, 300:2545-2547.
8. Haider A.W., Chen L., Larson M.G., Evans J.C., Chen M.H., Levy D. Antecedent hypertension confers increased risk for adverse outcomes after initial myocardial infarction. Hypertension 1997, 30:1020-1024.
9. Quan H., Khan N., Hemmelgarn B.R., et al. Validation of a case definition to define hypertension using administrative data. Hypertension 2009, 54:1423-1428.
10. Tu K., Campbell N.R.C., Chen Z.L., Cauch-Dudek K.J., McAlister F.A. Accuracy of administrative databases in identifying patients with hypertension. Open Medicine 2007, 1:3-5.
11. Kokotailo R.A., Hill M.D. Coding of stroke risk factors using ICD-10 and ICD-9. Stroke 2005, 36:1776-1781.
12. Quach S., Blair C., Quan H. Administrative data has high variation in validity for recording heart failure. Can J Cardiol 2010, 28:306-312.
13. Quan H., Li B., Saunders L.D., et al. Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. Health Serv Res 2008, 43:1424-1441.
14. Quan H., Sundararajan V., Halfon P., et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005, 43:1130-1139.
15. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
16. Ford E.S. Trends in mortality from all causes and cardiovascular disease among hypertensive and nonhypertensive adults in the United States. Circulation 2011, 123:1737-1744.
17. Robitaille C., Dai S., Waters C., et al. Diagnosed hypertension in Canada: incidence, prevalence and associated mortality. CMAJ 2012, 184:E49-E56.
18. McAlister F.A., Wilkins K., Joffres M., et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ 2011, 183:1007-1013.
19. McAlister F.A., Feldman R.D., Wyard K., Brant R., Campbell N.R. The impact of the CHEP in its first decade. Eur Heart J 2009, 30:1434-1439.
20. McAlister F.A., Robitaille C., Gillespie C., et al. The impact of cardiovascular risk-factor profiles on blood pressure control rates in adults from Canada and the United States. Can J Cardiol 2013, 29:598-605.
21. Smith E.R. The Canadian heart health strategy and action plan. Can J Cardiol 2009, 25:451-452.
22. Kaczorowski J., Chambers L.W., Dolovich L., et al. Improving cardiovascular health at population level 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP). BMJ 2011, 342:8.
23. Campbell N., Young E., Drouin D., et al. A framework for discussion on how to improve prevention, management and control of hypertension in Canada. Can J Cardiol 2012, 28:262-269.
24. Board on Population Health and Public Health Practice. A Population-Based Policy and Systems Change Approach to Prevent and Control Hypertension 2011, Committee on Public Health Priorities to Reduce and Control Hypertension in the U.S. Population, National Academies Press, Washington, DC.
25. Global health risks: mortality and burden of disease attributable to selected major risks 2009, World Health Organization, World Health Organization, Geneva.
26. Campbell N.R., Tu K., Brant R., Duong-Hua M., McAlister F.A. The impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends. Hypertension 2006, 47:22-28.
27. Campbell N.R., Brant R., Johansen H., et al. Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada. Hypertension 2009, 53:128-134.
28. Elliott W.J., Basu S., Meyer P.M. Network meta-analysis of heart failure prevention by antihypertensive drugs. Arch Intern Med 2011, 171:472-473.
29. Law M.R., Morris J.K., Wald N.J. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009, 338:b1665.
30. Smith S.C., Blair S.N., Criqui M.H., et al. Preventing heart attack and death in patients with coronary disease. Circulation 1995, 92:2-4.
31. Tu J.V., Nardi L., Fang J., Liu J., Khalid L., Johansen H. National trends in rates of death and hospital admissions related to acute myocardial infarction, heart failure and stroke, 1994-2004. CMAJ 2009, 180:E118-E125.
32. Wilkins K., Campbell N., Joffres M., et al. Blood pressure in Canadian adults. Health Rep 2010, 21:1-10.
33. Quan H., Fong A., De Coster C., et al. Variation in health services utilization among ethnic populations. CMAJ 2006, 174:787-791.